Cinausero, Marika Laprovitera, Noemi Maglio, Giovanna De Gerratana, Lorenzo Riefolo, Mattia Macerelli, Marianna Fiorentino, Michelangelo Porcellini, Elisa Buoro, Vanessa Gelsomino, Francesco Squadrilli, Anna Fasola, Gianpiero Negrini, Massimo Tiseo, Marcello Ferracin, Manuela Ardizzoni, Andrea Supplementary_table_2 – Supplemental material for KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC <p>Supplemental material, Supplementary_table_2 for KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC by Marika Cinausero, Noemi Laprovitera, Giovanna De Maglio, Lorenzo Gerratana, Mattia Riefolo, Marianna Macerelli, Michelangelo Fiorentino, Elisa Porcellini, Vanessa Buoro, Francesco Gelsomino, Anna Squadrilli, Gianpiero Fasola, Massimo Negrini, Marcello Tiseo, Manuela Ferracin and Andrea Ardizzoni in Therapeutic Advances in Medical Oncology</p> anti-PD-1;immunotherapy;nivolumab;non-small cell lung cancer;pembrolizumab 2019-11-16
    https://sage.figshare.com/articles/journal_contribution/Supplementary_table_2_Supplemental_material_for_KRAS_and_ERBB-family_genetic_alterations_affect_response_to_PD-1_inhibitors_in_metastatic_nonsquamous_NSCLC/10315562
10.25384/SAGE.10315562.v1